Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Stages II-III Breast Cancer × Doxorubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 24 Breast Neoplasms 21 Lymphoma, Large B-Cell, Diffuse 19 Precursor Cell Lymphoblastic Leukemia-Lymphoma 16 Neoplasms 13 Lymphoma 12 Ovarian Neoplasms 11 Burkitt Lymphoma 11 Neoplasm Metastasis 9 Lymphoma, Non-Hodgkin 8 Triple Negative Breast Neoplasms 7 Recurrence 7 Neuroblastoma 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma, T-Cell, Peripheral 5 Lymphoma, Large-Cell, Anaplastic 5 Lymphoma, Follicular 5 Lymphoma, B-Cell 5 Leukemia 5 Hodgkin Disease 5 Unspecified Adult Solid Tumor, Protocol Specific 4 Small Cell Lung Carcinoma 4 Prostatic Neoplasms 4 Multiple Myeloma 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 HIV Infections 4 Fallopian Tube Neoplasms 4 Carcinoma, Hepatocellular 4 Acquired Immunodeficiency Syndrome 4 Sarcoma, Kaposi 3

Interventions

Taxes 1 Doxorubicin 1 Cyclophosphamide 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01090128 2017-03-31

NAC

University of Utah

Phase 1 Terminated

Stages II-III Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡